We also quantitated the percentages of parenchymal cells that were CEBPB+ve or FGFR2+ve in CC and HB tumor and non-tumor livers, and found that the percentages of CEBPB+ve and FGRF2+ve parenchymal cells were not significantly different between the three groups. The gene discussed is FGFR2; the disease is neoplasm.